FDA Medical Product Approvals: Hearing Before the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, First Session, August 8, 1995
United States. Congress. House. Committee on Government Reform and Oversight. Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs
U.S. Government Printing Office, 1997 - Government paperwork - 55 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
agency American patients angioplasty atherosclerosis benefit breast implants Cardiologists Chairman CLIA clinical trial Committee Congress coronary arteries coronary investigator Corrections Day costs create David McIntosh defibrillator device approval device manufacturers drug Europe example FDA approval FDA reform Federal regulation field hearing Geier going Gutknecht HCFA's healthcare HEPA hospital implanted improve ingredient injectable aspirin issue labeling life-threatening look masks Mayo Clinic McINTOSH medical device industry medical innovation medical research medical technologies Medicare Medtronic MICHAEL MURPHY Minnesota Medical Association MURPHY Murray occluded office laboratories Olmsted Medical OSHA overly burdensome overseas pace PAP smear paperwork Paul Citron perform physicians problem procedures protect the public record regulatory reimbursement resulted Robert Schwartz Rochester safe safety Schwartz senior citizens specific stent subcommittee testimony tests Thank therapy things tuberculosis U.S. medical device United VETTER Wilkerson Report witnesses